Wu Sheng-Hua, Liao Pei-Yuan, Yin Pei-Ling, Zhang Yong-Mei, Dong Ling
Department of Pediatrics, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, People's Republic of China.
Prostaglandins Leukot Essent Fatty Acids. 2009 Apr;80(4):177-83. doi: 10.1016/j.plefa.2009.01.008. Epub 2009 Mar 4.
The pathogenesis of Henoch-Schönlein purpura (HSP) is not clearly understood. It remains unclear how changes of lipoxin A(4) (LXA(4)) that acts as a "braking signal" in inflammatory process occur in patients with HSP. In this study, we determined the temporal changes of blood and urinary LXA(4), Leukotriene (LT)B(4) and urinary LTE(4) in 49 children with HSP. Inverse temporal changes between gradually increased blood and urinary LXA(4) and gradually decreased blood and urinary LTB(4) and urinary LTE(4) were found in patients with HSP. Furthermore, both 15-S-hydroxyeicosatetraenoic acid and LXA(4) inhibited the LTB(4)-induced chemotaxis of leukocytes and release of LTB(4) from leukocytes obtained from the patients in the active phase of HSP. In 22 children with HSP nephritis, concordant with the gradually increased severity of mesangial proliferation and proteinuria, the glomerular expressions of 15-lipoxygenase and the levels of urinary LXA(4) gradually decreased and the glomerular expressions of LTC(4) synthase and the urinary LTE(4) and LTB(4) gradually increased. The levels of blood and urinary LXA(4) in patients with HSP nephritis were lower than those in patients with purpura alone in early resolution of HSP. The levels of blood and urinary LTB(4) and urinary LTE(4) in the patients with HSP nephritis were higher than those in patients with purpura alone in early resolution of HSP. There was positive correlation between blood LTB(4) and serum C-reactive protein in 49 children with HSP. These data suggest that LTs may play a proinflammatory and profibrotic role in the pathogenesis of HSP, and insufficiency of LXA(4) may be responsible for the patients with HSP whose illness become more serious.
过敏性紫癜(HSP)的发病机制尚不清楚。目前仍不清楚在HSP患者中,作为炎症过程中“制动信号”的脂氧素A(4)(LXA(4))是如何发生变化的。在本研究中,我们测定了49例HSP患儿血液和尿液中LXA(4)、白三烯(LT)B(4)和尿液LTE(4)随时间的变化。发现HSP患者血液和尿液中LXA(4)逐渐升高,而血液和尿液中LTB(4)和尿液LTE(4)逐渐降低,呈现相反的时间变化。此外,15 - S - 羟基二十碳四烯酸和LXA(4)均抑制了LTB(4)诱导的白细胞趋化作用以及活动期HSP患者白细胞释放LTB(4)。在22例HSP肾炎患儿中,随着系膜增生和蛋白尿严重程度逐渐增加,15 - 脂氧合酶的肾小球表达及尿液LXA(4)水平逐渐降低,而LTC(4)合酶的肾小球表达及尿液LTE(4)和LTB(4)逐渐升高。在HSP早期缓解时,HSP肾炎患者血液和尿液中LXA(4)水平低于单纯紫癜患者。在HSP早期缓解时,HSP肾炎患者血液和尿液中LTB(4)及尿液LTE(4)水平高于单纯紫癜患者。49例HSP患儿血液中LTB(4)与血清C反应蛋白呈正相关。这些数据表明,白三烯可能在HSP发病机制中起促炎和促纤维化作用,而LXA(4)不足可能是导致HSP患者病情加重的原因。